Swarajya

Our View
MagazineHeadlinesVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief

National Pharmaceutical Pricing Authority (NPPA)

Centre Takes Steps To Increase Antiviral Remdesivir Production From 38 Lakh Vials Per Month To 78 Lakh Vials Per Month
Centre Takes Steps To Increase Antiviral Remdesivir Production From 38 Lakh Vials Per Month To 78 Lakh Vials Per MonthSwarajya StaffApr 15, 2021 12:06 PM +05:30 IST
Government Caps Medical Oxygen Prices After Reports Of Shortage And Cost-Hike
Government Caps Medical Oxygen Prices After Reports Of Shortage And Cost-HikeIANSSep 26, 2020 05:13 PM +05:30 IST
National Pharmaceutical Pricing Authority Orders Price Cuts For Nine Major Anti-Cancer Drugs By Up To 87 Per Cent
National Pharmaceutical Pricing Authority Orders Price Cuts For Nine Major Anti-Cancer Drugs By Up To 87 Per CentSwarajya StaffMay 19, 2019 10:50 AM +05:30 IST
NPPA Data Shows Cancer Drugs Now 87 Per Cent Cheaper, Thanks To Government’s Decision To Cap Trade Margin
NPPA Data Shows Cancer Drugs Now 87 Per Cent Cheaper, Thanks To Government’s Decision To Cap Trade MarginSwarajya StaffMar 11, 2019 11:22 AM +05:30 IST
In A First, Kerala Sets Up Drug Price Monitoring And Research Unit To Curb Overcharging Of Medicines
In A First, Kerala Sets Up Drug Price Monitoring And Research Unit To Curb Overcharging Of MedicinesSwarajya StaffFeb 3, 2019 01:05 PM +05:30 IST
New ‘Advisory Committee’ Under NITI Aayog To Regulate Prices Of Medicines; NPPA Won’t Be Undermined, Says Centre
New ‘Advisory Committee’ Under NITI Aayog To Regulate Prices Of Medicines; NPPA Won’t Be Undermined, Says CentreSwarajya StaffJan 22, 2019 01:54 PM +05:30 IST
Indian Stents ‘Equally Good’ As The Best In The Market, Study Rubbishes Claims Of Superiority By Foreign Manufacturers
Indian Stents ‘Equally Good’ As The Best In The Market, Study Rubbishes Claims Of Superiority By Foreign ManufacturersSwarajya StaffNov 16, 2018 12:17 PM +05:30 IST
Year After 85 Per Cent Price Cut, Stent Price Now Increased Marginally
Year After 85 Per Cent Price Cut, Stent Price Now Increased MarginallySwarajya StaffFeb 13, 2018 04:00 PM +05:30 IST
In A Big Relief To Heart Patients, Government Caps Prices Of Coronary Stents
In A Big Relief To Heart Patients, Government Caps Prices Of Coronary StentsSwarajya StaffFeb 14, 2017 07:44 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype